Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings?
Carlo Foppiano Palacios, Amit Achhra, Lydia Barakat, Michael Virata, Ritche Hao, John Baxter, Maricar Malinis · 2026
Read Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings? by Carlo Foppiano Palacios, Amit Achhra, Lydia Barakat, Michael Virata, Ritche Hao, John Baxter, Maricar Malinis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13280639.txt.
Description
Carlo Foppiano Palacios and colleagues published a 2026 study on yearly testing for sleeping tuberculosis in people with HIV. Sleeping tuberculosis means the germs are in the body but cause no illness yet. The team worked in places where tuberculosis is rare. They tracked test results over five years at two large city health centers.
Of close to nineteen hundred patients tested at least twice, only twelve picked up a new infection. Yearly testing for everyone thus found very few cases. The authors say clinics should test the people most at risk, as current guidelines advise. That approach would save time and cost with little loss in safety.
Catalog record
| CREATOR | Carlo Foppiano Palacios, Amit Achhra, Lydia Barakat, Michael Virata, Ritche Hao, John Baxter, Maricar Malinis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17370 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |